Pharmacokinetics of cycloalliin, an organosulfur compound found in garlic and onion, in rats

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 26, 2006, Pages 9811-9819

  Ichikawa, Makoto ^a   Mizuno, Ikuko ^a   Yoshida, Jiro ^a   Ide, Nagatoshi ^a   Ushijima, Mitsuyasu ^a   Kodera, Yukihiro ^a   Hayama, Minoru ^a   Ono, Kazuhisa ^b  

^a WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cycloalliin; Garlic; Metabolite; Onion; Pharmacokinetics

Indexed keywords

CYCLOALLIIN; PIPECOLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMISTRY; FECES; GARLIC; KINETICS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; ONION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CHROMATOGRAPHY, LIQUID; FECES; GARLIC; KINETICS; MALE; MASS SPECTROMETRY; ONIONS; PIPECOLIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY;

ALLIUM CEPA; ALLIUM SATIVUM; RATTUS;

EID: 33846499812     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf062252a     Document Type: Article

References (44)

1. Lawson, L. D. The composition and chemistry of garlic cloves and processed garlic. In Garlic: The science and therapeutic application of Allium sativum L. and related species; Koch, H. P., Lawson, L. D., Eds.; Williams & Wilkins: Baltimore, MD, 1996; pp 37-107.
2. Amagase, H.; Petesch, B. L.; Matsuura, H.; Kasuga, S.; Itakura, Y. Intake of garlic and its bioactive components. J. Nutr. 2001, 131, 955S-962S.
3. Ichikawa, M.; Yoshida, J.; Ide, N.; Sasaoka, T.; Yamaguchi, H.; Ono, K. Tetrahydro-β-carboline derivatives in aged garlic extract show antioxidant properties. J. Nutr. 2006, 136, 726S-731S.
4. Ueda, Y.; Tsubuku, T.; Miyajima, R. Composition of sulfur-containing components in onion and their flavor characters. Biosci. Biotechnol. Biochem. 1994, 58, 108-110.
5. Ichikawa, M.; Ide, N.; Ono, K. Changes in organosulfur compounds in garlic cloves during storage. J. Agric. Food Chem. 2006, 54, 4849-4854.
6. Rahman, K. Garlic and aging: new insights into an old remedy. Ageing Res. Rev. 2003, 2, 39-56.
7. Kendler, B. S. Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. Prev. Med. 1987, 16, 670-685.
8. Agarwal, R. K.; Dewar, H. A.; Newell, D. J.; Das, B. Controlled trial of the effect of cycloalliin on the fibrinolytic activity of venous blood. Atherosclerosis 1977, 27, 347-51.
9. Yanagita, Y.; Han, S. Y.; Wang, Y. M.; Tsuruta, Y.; Anno, T. Cycloalliin, a cyclic sulfur imino acid reduces serum triglycerol in rats. Nutrition 2003, 19, 140-143.
10. Xiao, H.; Parkin, K. L. Antioxidant function of selected Allium thiosulfinates and S-alk(en)yl-L-cysteine sulfoxides. J. Agric. Food Chem. 2002, 50, 2488-2493.
11. Sakai, K.; Yoneda, N. Convenient synthesis of 1,4-thiazane-3-carboxylic acid derivatives. Chem. Pharm. Bull. 1981, 29, 1554-1560.
12. Kodera, Y.; Ichikawa, M.; Yoshida, J.; Kashimoto, N.; Uda, N.; Sumioka, I.; Ide, N.; Ono, K. Pharmacokinetic study of allixin, a phytoalexin produced by garlic. Chem. Pharm. Bull. 2002, 50, 354-363.
13. Tabata, K.; Yamaoka, K.; Kaibara, A.; Suzuki, S.; Terakawa, M.; Hata, T. Moment analysis program available on Microsoft Excel. Xenobiot. Metab. Dispos. 1999, 14, 286-293.
14. Brady, J. F.; Ishizaki, H.; Fukuto, J. M.; Lin, M. C.; Fadel, A.; Gapac, J. M.; Yang, C. S. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res. Toxicol. 1991, 4, 642-647.
15. Xie, Z.; Zhang, Y.; Xu, H.; Zhong, D. Pharmacokinetic difference between pantoprazole enantiomers in rats. Pharm. Res. 2005, 22, 1678-1684.
16. Etienne, F.; Resnick, L.; Sagher, D.; Brot, N.; Weissbach, H. Reduction of sulindac to its active metabolite, sulindac sulfide: assay and role of the methionine sulfoxide reductase system. Biochem. Biophys. Res. Commun. 2002, 290, 62-65.
17. Tamai, I.; Saheki, A.; Saitoh, R.; Sai, Y.; Yamada, I.; Tsuji, A. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters. J. Pharmacol. Exp. Ther. 1997, 283, 108-115.
18. Terao, T.; Hisanaga, E.; Sai, Y.; Tamai, I.; Tsuji, A. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J. Pharm. Pharmacol. 1996, 48, 1083-1089.
19. Meerum Terwogt, J. M.; Beijnen, J. H.; ten Bokkel Huinink, W. W.; Rosing, H.; Schellens, J. H. Co-administration of cyclosporin enables oral therapy with paclitaxel. Lancet 1998, 352, 285.
20. Arimori, K.; Nakano, M. Drug exsorption from blood into the gastrointestinal tract. Pharm. Res. 1998, 15, 371-376.
21. Yang, C. Y.; Dantzig, A. H.; Pidgeon, C. Intestinal peptide transport systems and oral drug availability. Pharm. Res. 1999, 16, 1331-1343.
22. Toyobuku, H.; Tamai, I.; Ueno, K.; Tsuji, A. Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug. J. Pharm. Sci. 2003, 92, 2249-2259.
23. Nagae, S.; Ushijima, M.; Hatono, S.; Imai, J.; Kasuga, S.; Matsuura, H.; Itakura, Y.; Higashi, Y. Pharmacokinetics of the garlic compound S-allylcysteine. Planta Med. 1994, 60, 214-217.
24. Schwind, E. C.; Eckard, R.; Jekat, F. W.; Winterhoff, H. Pharmacokinetics of vinyldithiins, transformation products of allicin. Planta Med. 1992, 58, 8-13.
25. Lawson, L. D.; Wang, Z. J. Allicin and allicin-derived garlic compounds increase breath acetone through allyl methyl sulfide: use in measuring allicin bioavailability. J. Agric. Food Chem. 2005, 53, 1974-1983.
26. Guo, Z.; Müller, D.; Pentz, R.; Kress, G.; Siegers, C.-P. Bioavailability of sulphur-containing ingredients of garlic in the rat. Planta Med. 1990, 56, 692.
27. Ide, N.; Lau, B. H. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κB activation. J. Nutr. 2001, 131, 1020S-1026S.
28. Morihara, N.; Ide, N.; Sumioka, I.; Kyo, E. Aged garlic extract inhibits peroxynitrite-induced hemolysis. Redox Rep. 2005, 10, 159-165.
29. Kim, K. M.; Chun, S. B.; Koo, M. S.; Choi, W. J.; Kim, T. W.; Kwon, Y. G.; Chung, H. T.; Billiar, T. R.; Kim, Y. M. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radical Biol. Med. 2001, 30, 747-756.
30. Amagase, H.; Milner, J. A. Impact of various sources of garlic and their constituents on 7,12-dimethylbenz(α)anthracene binding to mammary cell DNA. Carcinogenesis 1993, 14, 1627-1631.
31. Hatono, S.; Jimenez, A.; Wargovich, M. J. Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase. Carcinogenesis 1996, 17, 1014-1044.
32. Imai, J.; Ide, N.; Nagae, S.; Moriguchi, T.; Mastuura, H.; Itakura, Y. Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med. 1994, 60, 417-420.
33. Ide, N.; Lau, B. H. S. Garlic compounds protect vascular endothelial cells from oxidized low-density lipoprotein-induced injury. J. Pharm. Pharmacol. 1997, 49, 908-911.
34. Ho, S. E.; Ide, N.; Lau, B. H. S. S-Allyl cysteine reduces oxidant load in cells involved in the atherogenic process. Phytomedicine 2001, 8, 39-46.
35. Lachmann, G.; Lorenz, D.; Radeck, D.; Steiper, M. The pharmacokinetics of the S35 labeled labeled garlic constituents alliin, allicin and vinyldithiine. Arzneim. Forsch. 1994, 44, 734-743.
36. Aymard, C.; Seyer, L.; Chftel, J. C. Enzymatic reduction of methionine sulfoxide. In vitro experiments with rat liver and kidney. Agric. Biol. Chem. 1979, 43, 1869-1872.
37. Anders, M. W.; Ratnayake, J. H.; Hanna, P. E.; Fuchs, J. A. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol. Drug Metab. Dispos. 1981, 9, 307-310.
38. Fukuyama, H.; Tomisawa, H.; Ichihara, S.; Tteishi, M. Purification and properties of methyl sulfoxide reductases from rat kidney. Arch. Biochem. Biophys. 1987, 256, 480-489.
39. Kashiyama, E.; Yokoi, T.; Todaka, T.; Odomi, M.; Kamataki, T. Chiral inversion of drug: role of intestinal bacteria in the stereoselective sulphoxide reduction of flosequinan. Biochem. Pharmacol. 1994, 48, 237-243.
40. Renwick, A. G.; Evans, S. P.; Sweatman, T. W.; Cumberland, J.; George, C. F. The role of the gut flora in the reduction of sulphinpyrazone in the rat. Biochem. Pharmacol. 1982, 31, 2649-2656.
41. Duggan, D. E.; Hare, L. E.; Ditzler, C. A.; Lei, B. W.; Kwan, K. C. The disposition of sulindac. Clin. Pharmacol. Ther. 1977, 21, 326-335.
42. Weiner, J. H.; Macisaac, D. P.; Bishop, R. E.; Bilous, P. T. Purification and properties of Escherichia coli dimethyl sulfoxide reductase, an iron-sulfur molybdoenzyme with broad substrate specificity. J. Bacteriol. 1988, 170, 1505-1510.
43. Bilous, P. T.; Weiner, J. H. Molecular cloning and expression of the Escherichia coli dimethyl sulfoxide reductase operon. J. Bacteriol. 1988, 170, 1511-1518.
44. Pierson, D. E.; Campbell, A. Cloning and nucleotide sequence of bisC, the structural gene for biotin sulfoxide reductase in Escherichia coli. J. Bacteriol. 1990, 172, 2194-2198.